XML 32 R15.htm IDEA: XBRL DOCUMENT v3.25.4
Related Party Transactions
 12 Months Ended
Sep. 30, 2025
Related Party Transactions [Abstract]  
RELATED PARTY TRANSACTIONS

7. RELATED PARTY TRANSACTIONS

 

During the year ended September 30, 2024, Citius Pharma extended warrants held by our Chairman and Executive Vice Chairman (see Note 6) for 51,780 warrants on April 5, 2024, 156,863 warrants on August 7, 2024 and 111,732 warrants on September 25, 2024. During the year ended September 30, 2025, Citius Pharma extended warrants held by our Chairman and Executive Vice Chairman (see Note 6) for 156,863 warrants and 111,732 warrants on August 7, 2025.

 

See also Note 10 for Merger transaction and transactions consummated with our subsidiary to facilitate the Merger.

 

Citius Pharma is a party to a Shared Services Agreement with Citius Oncology. Under the terms of the agreement, the Citius Pharma provides all executive, operational, financial, and administrative support to Citius Oncology for a period of up to two (2) years. The quarterly allocated expense to Citius Oncology by Citius Pharma is currently approximately $1,006,000.